Search
Displaying results 621 to 630 of 669.
New coronavirus module in SORMAS
Scientists of the Department "Epidemiology" at the HZI lead by Prof Gérard Krause together with German and international partners developed the mobile information system SORMAS. The system operates as an application on mobile phones and is particularly suitable for use…
Expanding the therapeutic use of the antibiotic mupirocin
“Mupirocin is a highly effective antibiotic against methicillin-resistant Staphylococcus aureus (MRSA). However, this drug is rapidly inactivated by proteins in the blood and, therefore, can only be used for local application,” says Prof Eva Medina, head of the research…
Administrative Director Silke Tannapfel leaves the HZI
Silke Tannapfel has been Administrative Managing Director at the Helmholtz Centre for Infection Research (HZI) in Braunschweig since 1 October 2017 and will now leave the Centre at the end of December 2021. She will move to Wiesbaden on 1 January 2022 - with a new job…
Antibodies of vaccinated or hospitalized COVID-19 individuals still recognize the Omicron variant of SARS-CoV-2
The SARS-CoV-2 coronavirus carries different surface proteins, where Spike is the most prominent example and a crucial component of vaccine formulations. The Spike of the new Omicron variant has been investigated by a team of researchers from the Braunschweig University…
Flipping a molecular switch
Infections with the encephalomyocarditis virus (EMCV) affect a variety of mammals such as pigs and chimpanzees. However, humans can also become infected, resulting in fever and inflammatory disease. Like other cardioviruses – or like the highly infectious coronavirus…
Silver linings in the pandemic: Protein ZAP inhibits multiplication of SARS-CoV-2 by 20-fold
SARS-CoV-2 and other viruses whose genetic material consists of ribonucleic acids (RNA) use a propagation trick called programmed ribosomal reading frameshift. In doing so, these viruses prove to be masters of manipulation: they invade host cells and hijack the process…
Myxobacteria set sail
So far, citizen scientists have provided HIPS with over 700 soil samples from Saarland and other areas of Germany. From these samples, just as many new myxobacteria and several new natural products have already been identified. Some of these show promising properties…
Shedding light on the number of undetected SARS-CoV-2 infections
Even though many infections with SARS-CoV-2 cause only mild cold symptoms or are asymptomatic, the high total number of infections necessitates effective protective measures to protect the most vulnerable groups from severe courses of the disease. To this end, it is…
COR-101 is Inhibiting the Emerging Delta Variant of SARS-CoV-2
In the first step, the researchers isolated the genetic information of immune cells, which are producing anti-SARS-CoV-2 antibodies, from blood samples from local convalescent COVID-19 patients. From the collected antibody genes, they constructed a phage display…
NFDI4Microbiota celebrates success in second round of NFDI calls
“In our vision of the future, microbiology researchers will easily be able to translate existing research data into a deep understanding of microbial species and their molecular-level interactions,” says the consortium’s spokesman, Professor Konrad Förstner from ZB MED…
